Chinese Yam Surges +666% as TCM Meets Modern Probiotics

Executive Summary

Traditional Chinese medicine ingredients are transforming China's GI health market, with Chinese Yam (山药) surging +666% YoY and Astragalus (黄芪) growing +350% YoY as consumers embrace compound formulations combining probiotics with traditional remedies. While probiotics maintain market dominance with CN¥ 2.6 billion in sales and 60%+ category penetration, the "food-as-medicine" trend creates differentiation opportunities for brands bridging traditional wisdom with modern convenience.

Probiotics Market Maturity and Innovation Imperative

Probiotics dominate the GI health market with CN¥ 2.6 billion in Jan-Sep 2025 sales and over 60% category penetration. However, growth has moderated to +3.8% YoY as the segment matures. This deceleration creates pressure for brands to differentiate through strain customization, scenario-specific positioning, and ingredient innovation.

The GI probiotics segment reached its peak in 2023 at CN¥ 4.18 billion before declining slightly in 2024. Projected full-year 2025 sales will exceed CN¥ 3.7 billion, representing +6.7% YoY growth driven by rising demand and supply-side breakthrough measures.

GI probiotics projected to reach CN¥ 3.7 billion in 2025 after 2024 dip

Traditional Chinese Medicine Ingredient Explosion

TCM ingredients are accelerating penetration with triple-digit growth rates across multiple categories. Astragalus (黄芪), Chinese Yam (山药), and Poria (茯苓) appear primarily in compound formulations combining probiotics with hawthorn and chicken gizzard membrane. These products target the traditional "digestion, wellness, nourishment" TCM framework for gentler, safer GI care.

Chinese Yam shows explosive +666% growth; probiotics mature at +3.8% YoY

Brand Competition Intensifies Through Channel Innovation

Competition among brands intensifies as Jiangzhong (江中) and Purmeo (普美欧) gained over 2 percentage points in market share through Douyin channel expansion. Their strategies include multi-placement traffic acquisition, live broadcast partnerships through official account matrices, and leveraging platform promotional campaigns.

Jiangzhong gains +2.2pp share; Wonderlab declines -3.7pp as competition intensifies

Pricing Strategy and Dosage Form Innovation

Probiotic prices concentrate in the CN¥ 50-500 range, with high-end and low-end segments showing seasonal fluctuations. Products above CN¥ 750 accounted for nearly 10% of sales during major promotional periods (Double 11, 618 Festival), driven by head brand large-volume combo pack promotions.

The CN¥ 150-300 range consistently captures ~29-32% of sales, representing the sweet spot for mainstream consumer adoption. Premium segments show volatility during promotional periods, reaching 10.5% in November 2024 during Double 11.

Emerging dosage forms show strong momentum:

• Drops grew +78% YoY, targeting infant markets for easy meal integration
• Chewable Tablets grew +48% YoY, offering flavor variety for enjoyable supplement experiences
• Powder/Granule maintains 76% dominance as the traditional format

Drops surge +78% YoY; powder/granule maintains 76% dominance

Consumer Focus: Efficacy Dominates Purchase Decisions

Consumer feedback reveals efficacy (79%) as the dominant purchase driver, with side effects (17%) and flavor (16%) as secondary considerations. Claims targeting constipation relief, bloating reduction, and breath improvement drive purchasing decisions.

Efficacy dominates consumer focus at 79%; flavor optimization presents differentiation opportunity

Strategic Implications for Brands

The convergence of TCM ingredients with modern probiotics creates differentiation opportunities for brands positioning scientifically-validated traditional remedies for modern wellness lifestyles. Brands can capitalize on the "food-as-medicine" trend by developing compound products bridging traditional wisdom with modern convenience.

Winning strategies include:

• Combining high-growth TCM ingredients with established probiotic strains
• Leveraging Douyin live commerce for market share gains
• Developing convenient dosage forms targeting specific consumer segments
• Building efficacy-focused communication with clinical validation

Key Takeaways

• Chinese Yam surged +666% YoY, leading explosive TCM ingredient growth
• Probiotics maintain CN¥ 2.6 billion dominance but mature at +3.8% growth
• Jiangzhong and Purmeo gained +2pp market share through Douyin strategies
• Drops dosage form grew +78% YoY, targeting infant segment
• Efficacy drives 79% of consumer purchase decisions

About the Data

This analysis draws on Moojing Market Intelligence data covering Jan-Sep 2025. Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail GMV. For full methodology and additional insights, see the complete GI Health Supplements whitepaper.